Gender-related differences in the presentation and course of Cushing's disease

Research output: Contribution to journalArticle

106 Citations (Scopus)

Abstract

Cushing's disease (CD) presents a marked female preponderance, but whether this skewed gender distribution has any relevance to the presentation and outcome of CD is not known. The aim of the present study was the comparison of clinical features, biochemical indices of hypercortisolism, and surgical outcome among male and female patients with CD. The study population comprised 280 patients with CD (233 females, 47 males) collected by the Italian multicentre study. Epidemiological data, frequency of clinical signs and symptoms, urinary free cortisol (UFC), plasma ACTH and cortisol levels, responses to dynamic testing, and surgical outcome were compared in female and male patients. Male patients with CD presented at a younger age, compared with females (30.5 ± 1.93 vs. 37.1 ± 0.86 yr, P <0.01), with higher UFC and ACTH levels (434.1 ± 51.96 vs. 342.1 ± 21.01% upper limit of the normal range for UFC, P <0.05; 163.9 ± 22.92 vs. 117.7 ± 9.59% upper limit of the normal range for ACTH, P <0.05). No difference in ACTH and cortisol responses to CRH, gradient at inferior petrosal sinus sampling, and cortisol inhibition after low-dose dexamethasone was recorded between sexes. In contrast, the sensitivity of the high-dose dexamethasone test was significantly lower in male than in female patients. Of particular interest, symptoms indicative of hypercatabolic state were more frequent in male patients; indeed, males presented a higher prevalence of osteoporosis, muscle wasting, striae, and nephrolitiasis. Conversely, no symptom was more frequent in female patients with CD. Patients with myopathy, hypokalemia, and purple striae presented significantly higher UFC levels, compared with patients without these symptoms. Lastly, in male patients, pituitary imaging was more frequently negative and immediate and late surgical outcome less favorable. In conclusion, CD appeared at a younger age and with a more severe clinical presentation in males, compared with females, together with more pronounced elevation of cortisol and ACTH levels. Furthermore, high-dose dexamethasone suppression test and pituitary imaging were less reliable in detecting the adenoma in male patients, further burdening the differential diagnosis with ectopic ACTH secretion. Lastly, the postsurgical course of the disease carried a worse prognosis in males. Altogether, these findings depict a different pattern for CD in males and females.

Original languageEnglish
Pages (from-to)1554-1558
Number of pages5
JournalJournal of Clinical Endocrinology and Metabolism
Volume88
Issue number4
DOIs
Publication statusPublished - Apr 1 2003

Fingerprint

Pituitary ACTH Hypersecretion
Hydrocortisone
Adrenocorticotropic Hormone
Dexamethasone
Imaging techniques
Petrosal Sinus Sampling
Reference Values
Hypokalemia
Muscle
Cushing Syndrome
Muscular Diseases
Adenoma
Sampling
Osteoporosis
Multicenter Studies
Signs and Symptoms
Plasmas
Differential Diagnosis

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Gender-related differences in the presentation and course of Cushing's disease. / Giraldi, Francesca Pecori; Moro, Mirella; Cavagnini, Francesco.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 88, No. 4, 01.04.2003, p. 1554-1558.

Research output: Contribution to journalArticle

@article{72f539b55bfa498a99b86cbf93f27823,
title = "Gender-related differences in the presentation and course of Cushing's disease",
abstract = "Cushing's disease (CD) presents a marked female preponderance, but whether this skewed gender distribution has any relevance to the presentation and outcome of CD is not known. The aim of the present study was the comparison of clinical features, biochemical indices of hypercortisolism, and surgical outcome among male and female patients with CD. The study population comprised 280 patients with CD (233 females, 47 males) collected by the Italian multicentre study. Epidemiological data, frequency of clinical signs and symptoms, urinary free cortisol (UFC), plasma ACTH and cortisol levels, responses to dynamic testing, and surgical outcome were compared in female and male patients. Male patients with CD presented at a younger age, compared with females (30.5 ± 1.93 vs. 37.1 ± 0.86 yr, P <0.01), with higher UFC and ACTH levels (434.1 ± 51.96 vs. 342.1 ± 21.01{\%} upper limit of the normal range for UFC, P <0.05; 163.9 ± 22.92 vs. 117.7 ± 9.59{\%} upper limit of the normal range for ACTH, P <0.05). No difference in ACTH and cortisol responses to CRH, gradient at inferior petrosal sinus sampling, and cortisol inhibition after low-dose dexamethasone was recorded between sexes. In contrast, the sensitivity of the high-dose dexamethasone test was significantly lower in male than in female patients. Of particular interest, symptoms indicative of hypercatabolic state were more frequent in male patients; indeed, males presented a higher prevalence of osteoporosis, muscle wasting, striae, and nephrolitiasis. Conversely, no symptom was more frequent in female patients with CD. Patients with myopathy, hypokalemia, and purple striae presented significantly higher UFC levels, compared with patients without these symptoms. Lastly, in male patients, pituitary imaging was more frequently negative and immediate and late surgical outcome less favorable. In conclusion, CD appeared at a younger age and with a more severe clinical presentation in males, compared with females, together with more pronounced elevation of cortisol and ACTH levels. Furthermore, high-dose dexamethasone suppression test and pituitary imaging were less reliable in detecting the adenoma in male patients, further burdening the differential diagnosis with ectopic ACTH secretion. Lastly, the postsurgical course of the disease carried a worse prognosis in males. Altogether, these findings depict a different pattern for CD in males and females.",
author = "Giraldi, {Francesca Pecori} and Mirella Moro and Francesco Cavagnini",
year = "2003",
month = "4",
day = "1",
doi = "10.1210/jc.2002-021518",
language = "English",
volume = "88",
pages = "1554--1558",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "4",

}

TY - JOUR

T1 - Gender-related differences in the presentation and course of Cushing's disease

AU - Giraldi, Francesca Pecori

AU - Moro, Mirella

AU - Cavagnini, Francesco

PY - 2003/4/1

Y1 - 2003/4/1

N2 - Cushing's disease (CD) presents a marked female preponderance, but whether this skewed gender distribution has any relevance to the presentation and outcome of CD is not known. The aim of the present study was the comparison of clinical features, biochemical indices of hypercortisolism, and surgical outcome among male and female patients with CD. The study population comprised 280 patients with CD (233 females, 47 males) collected by the Italian multicentre study. Epidemiological data, frequency of clinical signs and symptoms, urinary free cortisol (UFC), plasma ACTH and cortisol levels, responses to dynamic testing, and surgical outcome were compared in female and male patients. Male patients with CD presented at a younger age, compared with females (30.5 ± 1.93 vs. 37.1 ± 0.86 yr, P <0.01), with higher UFC and ACTH levels (434.1 ± 51.96 vs. 342.1 ± 21.01% upper limit of the normal range for UFC, P <0.05; 163.9 ± 22.92 vs. 117.7 ± 9.59% upper limit of the normal range for ACTH, P <0.05). No difference in ACTH and cortisol responses to CRH, gradient at inferior petrosal sinus sampling, and cortisol inhibition after low-dose dexamethasone was recorded between sexes. In contrast, the sensitivity of the high-dose dexamethasone test was significantly lower in male than in female patients. Of particular interest, symptoms indicative of hypercatabolic state were more frequent in male patients; indeed, males presented a higher prevalence of osteoporosis, muscle wasting, striae, and nephrolitiasis. Conversely, no symptom was more frequent in female patients with CD. Patients with myopathy, hypokalemia, and purple striae presented significantly higher UFC levels, compared with patients without these symptoms. Lastly, in male patients, pituitary imaging was more frequently negative and immediate and late surgical outcome less favorable. In conclusion, CD appeared at a younger age and with a more severe clinical presentation in males, compared with females, together with more pronounced elevation of cortisol and ACTH levels. Furthermore, high-dose dexamethasone suppression test and pituitary imaging were less reliable in detecting the adenoma in male patients, further burdening the differential diagnosis with ectopic ACTH secretion. Lastly, the postsurgical course of the disease carried a worse prognosis in males. Altogether, these findings depict a different pattern for CD in males and females.

AB - Cushing's disease (CD) presents a marked female preponderance, but whether this skewed gender distribution has any relevance to the presentation and outcome of CD is not known. The aim of the present study was the comparison of clinical features, biochemical indices of hypercortisolism, and surgical outcome among male and female patients with CD. The study population comprised 280 patients with CD (233 females, 47 males) collected by the Italian multicentre study. Epidemiological data, frequency of clinical signs and symptoms, urinary free cortisol (UFC), plasma ACTH and cortisol levels, responses to dynamic testing, and surgical outcome were compared in female and male patients. Male patients with CD presented at a younger age, compared with females (30.5 ± 1.93 vs. 37.1 ± 0.86 yr, P <0.01), with higher UFC and ACTH levels (434.1 ± 51.96 vs. 342.1 ± 21.01% upper limit of the normal range for UFC, P <0.05; 163.9 ± 22.92 vs. 117.7 ± 9.59% upper limit of the normal range for ACTH, P <0.05). No difference in ACTH and cortisol responses to CRH, gradient at inferior petrosal sinus sampling, and cortisol inhibition after low-dose dexamethasone was recorded between sexes. In contrast, the sensitivity of the high-dose dexamethasone test was significantly lower in male than in female patients. Of particular interest, symptoms indicative of hypercatabolic state were more frequent in male patients; indeed, males presented a higher prevalence of osteoporosis, muscle wasting, striae, and nephrolitiasis. Conversely, no symptom was more frequent in female patients with CD. Patients with myopathy, hypokalemia, and purple striae presented significantly higher UFC levels, compared with patients without these symptoms. Lastly, in male patients, pituitary imaging was more frequently negative and immediate and late surgical outcome less favorable. In conclusion, CD appeared at a younger age and with a more severe clinical presentation in males, compared with females, together with more pronounced elevation of cortisol and ACTH levels. Furthermore, high-dose dexamethasone suppression test and pituitary imaging were less reliable in detecting the adenoma in male patients, further burdening the differential diagnosis with ectopic ACTH secretion. Lastly, the postsurgical course of the disease carried a worse prognosis in males. Altogether, these findings depict a different pattern for CD in males and females.

UR - http://www.scopus.com/inward/record.url?scp=0037684726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037684726&partnerID=8YFLogxK

U2 - 10.1210/jc.2002-021518

DO - 10.1210/jc.2002-021518

M3 - Article

VL - 88

SP - 1554

EP - 1558

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 4

ER -